Epratuzumab

Epratuzumab Uses, Dosage, Side Effects, Food Interaction and all others data.

Epratuzumab is a humanized monoclonal antibody derived from the murine IG2a monoclonal antibody, LL2 (EPB-2). This agent may subsequently be well matched for use in oncology and the treatment of inflammatory autoimmune disorders, such as lupus.

Trade Name Epratuzumab
Generic Epratuzumab
Epratuzumab Other Names Epratuzumab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Epratuzumab
Epratuzumab

Uses

Investigated for use/treatment in leukemia (lymphoid), lymphoma (non-hodgkin's), and systemic lupus erythematosus.

How Epratuzumab works

Epratuzumab is a recombinant, humanized monoclonal antibody directed against CD22, a cell surface glycoprotein present on mature B-cells and on many types of malignant B-cells. It binds with high specificity to normal B-cells and B-cell tumors at the third Ig-like domain of CD22. After binding to CD22, epratuzumab's predominant antitumor activity appears to be mediated through antibody-dependent cellular cytotoxicity (ADCC).

Innovators Monograph

You find simplified version here Epratuzumab

*** Taking medicines without doctor's advice can cause long-term problems.
Share